Erratum: Modified high-molecular-weight hyaluronan promotes allergen-specific immune tolerance (American Journal of Respiratory Cell and Molecular Biology (2017) 56 (109-120) DOI: 10.1165/rcmb.2016-0111OC);Modified high-molecular-weight hyaluronan promotes allergen-specific immune tolerance

American Journal of Respiratory Cell and Molecular Biology

Volumn 56, Issue 1, 2017, Pages 109-120

  Gebe, John A ^a   Yadava, Koshika ^b,c   Ruppert, Shannon M ^b,c   Marshall, Payton ^c   Hill, Paul ^d   Falk, Ben A ^c   Sweere, Johanna M ^b,c   Han, Hongwei ^a   Kaber, Gernot ^b   Medina, Carlos ^b,c   Mikecz, Katalin ^e   Ziegler, Steven F ^a   Balaji, Swathi ^f   Keswani, Sundeep G ^f   De Jesus Perez, Vinicio A ^g   Butte, Manish J ^c   Nadeau, Kari ^g   Altemeier, William A ^h   Fanger, Neil ^d   Bollyky, Paul L ^a,b,c  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Stanford Immunology   (United States)

^d Virtici LLC   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allergy; Dendritic cell; Hyaluronan; T cell; Tolerance

Indexed keywords

HIGH MOLECULAR WEIGHT HYALURONAN; HYALURONIC ACID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; OVALBUMIN; UNCLASSIFIED DRUG; ALLERGEN; ANTIINFLAMMATORY AGENT; CROSS LINKING REAGENT; HERMES ANTIGEN; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATABOLISM; CELL COUNT; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DESENSITIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; MOUSE MODEL; NONHUMAN; RESPIRATORY TRACT ALLERGY; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MOLECULAR WEIGHT; PATHOLOGY; PATHOPHYSIOLOGY; PNEUMONIA; PROTEIN TRANSPORT; TRANSGENIC MOUSE;

ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD44; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CROSS-LINKING REAGENTS; DENDRITIC CELLS; HYALURONIC ACID; IMMUNE TOLERANCE; IMMUNIZATION; INTERLEUKIN-10; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR WEIGHT; NF-KAPPA B; PNEUMONIA; PROTEIN TRANSPORT; SULFHYDRYL COMPOUNDS;

EID: 85008442830     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2016-0111OC     Document Type: Erratum

References (55)

1. Laurent TC, Laurent UB, Fraser JR. The structure and function of hyaluronan: an overview. Immunol Cell Biol 1996;74:A1-A7.
2. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011;91:221-264.
3. Noble PW, Jiang D. Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc Am Thorac Soc 2006;3:401-404.
4. Lauer ME, Majors AK, Comhair S, Ruple LM, Matuska B, Subramanian A, Farver C, Dworski R, Grandon D, Laskowski D, et al. Hyaluronan and its heavy chain modification in asthma severity and experimental asthma exacerbation. J Biol Chem 2015;290:23124-23134.
5. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997;242:27-33.
6. Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, Nepom GT. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD41CD251 regulatory T cells. J Immunol 2007;179:744-747.
7. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005;11:1173-1179.
8. Huang P-M, Syrkina O, Yu L, Dedaj R, Zhao H, Shiedlin A, Liu Y-Y, Garg H, Quinn DA, Hales CA. High MW hyaluronan inhibits smoke inhalation-induced lung injury and improves survival. Respirology 2010;15:1131-1139.
9. Galeano M, Polito F, Bitto A, Irrera N, Campo GM, Avenoso A, CalòM, Cascio Lo P, Minutoli L, Barone M, et al. Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice. Biochim Biophys Acta 2011;1812:752-759.
10. Bollyky PL, Wu RP, Falk BA, Lord JD, Long SA, Preisinger A, Teng B, Holt GE, Standifer NE, Braun KR, et al. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci USA 2011;108:7938-7943.
11. Lazrak A, Creighton J, Yu Z, Komarova S, Doran SF, Aggarwal S, Emala CW Sr, Stober VP, Trempus CS, Garantziotis S, et al. Hyaluronan mediates airway hyperresponsiveness in oxidative lung injury. Am J Physiol Lung Cell Mol Physiol 2015;308:L891-L903.
12. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, Nevo E, Gorbunova V, Seluanov A. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 2013;499:346-349.
13. Neumann A, Schinzel R, Palm D, Riederer P, Münch G. High molecular weight hyaluronic acid inhibits advanced glycation endproductinduced NF-kB activation and cytokine expression. FEBS Lett 1999; 453:283-287.
14. Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980;40:435-446.
15. Ruppert SM, Hawn TR, Arrigoni A, Wight TN, Bollyky PL. Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol Res 2014;58:186-192.
16. Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 2006;106:818-839.
17. Noble PW, McKee CM, Cowman M, Shin HS. Hyaluronan fragments activate an NF-kB/I-kB alpha autoregulatory loop in murine macrophages. J Exp Med 1996;183:2373-2378.
18. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996;98:2403-2413.
19. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J Exp Med 2002;195:99-111.
20. Termeer CC, Hennies J, Voith U, Ahrens T,Weiss JM, Prehm P, Simon JC. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165:1863-1870.
21. de la Motte C, Nigro J, Vasanji A, Rho H, Kessler S, Bandyopadhyay S, Danese S, Fiocchi C, Stern R. Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. Am J Pathol 2009;174: 2254-2264.
22. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006;177:1272-1281.
23. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004;279:17079-17084.
24. Garantziotis S, Li Z, Potts EN, Lindsey JY, Stober VP, Polosukhin VV, Blackwell TS, Schwartz DA, Foster WM, Hollingsworth JW. TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J Respir Crit Care Med 2010;181:666-675.
25. Liang J, Jiang D, Jung Y, Xie T, Ingram J, Church T, Degan S, Leonard M, Kraft M, Noble PW. Role of hyaluronan and hyaluronan-binding proteins in human asthma. J Allergy Clin Immunol 2011;128:403-411.e3.
26. Ayars AG, Altman LC, Potter-Perigo S, Radford K, Wight TN, Nair P. Sputum hyaluronan and versican in severe eosinophilic asthma. Int Arch Allergy Immunol 2013;161:65-73.
27. Cheng G, Swaidani S, Sharma M, Lauer ME, Hascall VC, Aronica MA. Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. Matrix Biol 2011;30:126-134.
28. Ghosh S, Hoselton SA, Dorsam GP, Schuh JM. Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease. Immunobiology 2015;220:575-588.
29. Jiang D, Liang J, Li Y, Noble PW. The role of Toll-like receptors in noninfectious lung injury. Cell Res 2006;16:693-701.
30. Cyphert JM, Trempus CS, Garantziotis S. Size matters: molecular weight specificity of hyaluronan effects in cell biology. Int J Cell Biol 2015;2015:563818.
31. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006;85:699-715.
32. Bollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, Nepom GT. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD41CD251 regulatory T cells. J Leukoc Biol 2009;86: 567-572.
33. Hutás G, Bajnok E, Gál I, Finnegan A, Glant TT, Mikecz K. CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood 2008;112:4999-5006.
34. Bates JH. Pulmonary mechanics: a system identification perspective. Conf Proc IEEE Eng Med Biol Soc 2009;2009:170-172.
35. Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, Gyarmati D, Aye T, Campbell DJ, Ziegler SF. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005;6:1047-1053.
36. Arizmendi NG, Abel M, Mihara K, Davidson C, Polley D, Nadeem A, El Mays T, Gilmore BF, Walker B, Gordon JR, et al. Mucosal allergic sensitization to cockroach allergens is dependent on proteinase activity and proteinase-activated receptor-2 activation. J Immunol 2011;186:3164-3172.
37. Akdis CA, Akdis M. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest 2014;124:4678-4680.
38. Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, Evanko SP, Buckner JH, Wight TN, Nepom GT. CD44 costimulation promotes FoxP31 regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-b. J Immunol 2009;183:2232-2241.
39. Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, Vanhoutte L, Neyt K, Killeen N, Malissen B, et al. Conventional and monocyte-derived CD11b1 dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013;38:322-335.
40. Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MAM, Kool M, Muskens F, Lambrecht BN. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 2010;207:2097-2111.
41. Plantinga M, Hammad H, Lambrecht BN. Origin and functional specializations of DC subsets in the lung. Eur J Immunol 2010;40: 2112-2118.
42. Mizrahy S, Raz SR, Hasgaard M, Liu H, Soffer-Tsur N, Cohen K, Dvash R, Landsman-Milo D, Bremer MGEG, Moghimi SM, et al. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J Control Release 2011;156:231-238.
43. Wolny PM, Banerji S, Gounou C, Brisson AR, Day AJ, Jackson DG, Richter RP. Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan. J Biol Chem 2010;285: 30170-30180.
44. Liang J, Jiang D, Griffith J, Yu S, Fan J, Zhao X, Bucala R, Noble PW. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 2007;178:2469-2475.
45. Kawana H, Karaki H, Higashi M, Miyazaki M, Hilberg F, Kitagawa M, Harigaya K. CD44 suppresses TLR-mediated inflammation. J Immunol 2008;180:4235-4245.
46. Muto J, Yamasaki K, Taylor KR, Gallo RL. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol 2009;47:449-456.
47. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, PuréE, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science 2002; 296:155-158.
48. Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD251CD41 Tr cells. Blood 2005;105:1162-1169.
49. Yasuda T. Hyaluronan inhibits Akt, leading to nuclear factor-kB downregulation in lipopolysaccharide-stimulated U937 macrophages. J Pharmacol Sci 2011;115:509-515.
50. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218-230.
51. Knudsen KB, Northeved H, Ek PK, Permin A, Andresen TL, Larsen S, Wegener KM, Lam HR, Lykkesfeldt J. Differential toxicological response to positively and negatively charged nanoparticles in the rat brain. Nanotoxicology 2014;8: 764-774.
52. Bonner JC. Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc Am Thorac Soc 2010;7:138-141.
53. Prestwich GD, Kuo J-W. Chemically-modified HA for therapy and regenerative medicine. Curr Pharm Biotechnol 2008;9: 242-245.
54. Kogan G, Soltés L, Stern R, Gemeiner P. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett 2007;29:17-25.
55. Prestwich GD, Erickson IE, Zarembinski TI, West M, Tew WP. The translational imperative: making cell therapy simple and effective. Acta Biomater 2012;8:4200-4207.